Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith McCrae

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Hematology|June 16, 2018
An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution"Michael B Streiff, Dejan Milentijevic, Keith McCrae, et al.
Orphanet Journal of Rare Diseases|August 7, 2025
Exploring patients' experiences with wAIHA and the content validity of the FACIT-fatigue: a qualitative interview studyAnubha Shukla, Owen Cooper, Karen Jones, et al.
American Journal of Hematology|February 4, 2018
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancerMichael B Streiff, Dejan Milentijevic, Keith McCrae, et al.
Thrombosis Research|March 8, 2016
A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formationYasin Kokoye, Ivan Ivanov, Qiufang Cheng, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Blood|December 29, 2018
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chainIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.
Journal of Ovarian Research|June 27, 2023
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancerGoutam Dey, Rashmi Bharti, Chad Braley, et al.
JNCI Cancer Spectrum|July 31, 2019
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort StudyDavendra P S Sohal, Nicole M Kuderer, Frances A Shepherd, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell diseaseErica M Sparkenbaugh, Malgorzata Kasztan, Michael W Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416Afshin Dowlati, Kelly Robertson, Tomas Radivoyevitch, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Hematology|June 16, 2018
An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution"Michael B Streiff, Dejan Milentijevic, Keith McCrae, et al.
Orphanet Journal of Rare Diseases|August 7, 2025
Exploring patients' experiences with wAIHA and the content validity of the FACIT-fatigue: a qualitative interview studyAnubha Shukla, Owen Cooper, Karen Jones, et al.
American Journal of Hematology|February 4, 2018
Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancerMichael B Streiff, Dejan Milentijevic, Keith McCrae, et al.
Thrombosis Research|March 8, 2016
A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formationYasin Kokoye, Ivan Ivanov, Qiufang Cheng, et al.
Targeted Oncology|November 6, 2021
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with ImmunotherapyIris Y Sheng, Shilpa Gupta, Chandana A Reddy, et al.
Blood|December 29, 2018
A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chainIvan Ivanov, Anton Matafonov, Mao-Fu Sun, et al.
Journal of Ovarian Research|June 27, 2023
LCK facilitates DNA damage repair by stabilizing RAD51 and BRCA1 in the nucleus of chemoresistant ovarian cancerGoutam Dey, Rashmi Bharti, Chad Braley, et al.
JNCI Cancer Spectrum|July 31, 2019
Clinical Predictors of Early Mortality in Colorectal Cancer Patients Undergoing Chemotherapy: Results From a Global Prospective Cohort StudyDavendra P S Sohal, Nicole M Kuderer, Frances A Shepherd, et al.
Journal of Thrombosis and Haemostasis : JTH|June 24, 2020
High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell diseaseErica M Sparkenbaugh, Malgorzata Kasztan, Michael W Henderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Novel Phase I dose de-escalation design trial to determine the biological modulatory dose of the antiangiogenic agent SU5416Afshin Dowlati, Kelly Robertson, Tomas Radivoyevitch, et al.
Pageof 4